GHK-Cu affects over 4,000 human genes according to research, with particularly strong influences on genes related to tissue remodeling, antioxidant protection, and cellular regeneration
Lexaria believes its technology can improve patient experience particularly by reducing side effects, positioning it as a valuable partner for pharmaceutical companies entering or expanding within the oral GLP-1 market
Experts say this dual approach represents a new, evidence-based strategy for managing menopause-related weight gain
We cover: Why chasing healthcare superintelligence misses the point How Color uses AI to speed up care and not take over decision-making Their pivot from genetic testing to full-scale clinical delivery How they cut time to treatment in half and boosted screening by 70% Partnering with OpenAI, Memorial Sloan Kettering, and major employers Tune in wherever you listen to podcasts
Protein becomes the most important macronutrient